middle.news
How Entropy’s New Patent Locks Down Precision IV Psychedelic Therapy Until 2042
8:46am on Thursday 12th of February, 2026 AEDT
•
Biotechnology
Read Story
How Entropy’s New Patent Locks Down Precision IV Psychedelic Therapy Until 2042
8:46am on Thursday 12th of February, 2026 AEDT
Key Points
Australian patent granted for precision-controlled two-phase IV dosing method
Protection extends to psilocybin, psilocin, and related compounds through 2042
Patent covers rapid onset, controlled maintenance, treatment stoppage, and EEG monitoring
Broad application across neuropsychiatric and nociplastic pain disorders
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
ENP
OPEN ARTICLE